Video

Precision Medicine: Chaired by Jason Luke, MD

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Speakers

  • Daniel P. Petro, MD | UPMC Hillman Cancer Center
  • Timothy F. Burns, MD, PhD | UPMC Hillman Cancer Center
  • Phuong L. Mai, MD | UPMC Hillman Cancer Center
  • Lan G. Coffman, MD, PhD | UPMC Hillman Cancer Center
  • Nathan Bahary, MD, PhD | UPMC Hillman Cancer Center

Topics

  • Review of Options
  • Molecular Targets in Lung Cancer
  • Germline Testing (Cancer Syndromes)
  • EGFR Inhibition: Translational and Clinical Insights (Plenary)
  • GYN/Breast
  • GI Tumors (Gastric, CRC, Cholangiocarcinoma)
Related Videos
Adam M. Brufsky, MD, PhD, FACP
Video 8 - 2 KOLs are featured in, "Emerging Trials in the Management of HR+/HER2- mBC"
Video 7 - 2 KOLs are featured in, "Adverse Event Data and Management for Optimal Quality of Life in HR+/HER2- mBC"
Video 6 - 2 KOLs are featured in, "Other trials of note investigating targeted therapies in later line HR+/HER2- mBC"
Adam M. Brufsky, MD, PhD, and Erika P. Hamilton, MD, experts on breast cancer
Kathleen A. Dorritie, MD
Video 4 - 2 KOLs are featured in, "Clinical Decision Making to Overcome Treatment Resistance in 2L HR+ HER2- mBC"
Video 2 - 2 KOLs are featured in, "Mechanisms of Resistance after 1L CDK4/6i + ET: The PI3K/AKT/PTEN Pathway"
This series features 2 KOLs
This series features 2 KOLs